Grifols (GIKLY) Net Cash Flow (2010 - 2019)
Grifols (GIKLY) posted Net Cash Flow of -$130.2 million for Q1 2020, up 59.92% quarter-over-quarter from -$324.9 million in Q4 2019, and up 75.96% year-on-year from -$74.0 million in Q2 2019.
Grifols (GIKLY) Net Cash Flow (2010 - 2019) Analysis & Trends
Grifols (GIKLY) has reported Net Cash Flow for 10 consecutive years, with -$130.2 million the latest figure, recorded in Q1 2020.
- Net Cash Flow for Q1 2020 came in at -$130.2 million, up 75.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.0 (changed 0.0% YoY), and the FY2025 annual result was -$71.0 million, down 115.49% from the prior year.
- Net Cash Flow was -$130.2 million for Q1 2020 at Grifols, up from -$324.9 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $4.9 billion in Q4 2017 and troughed at -$604.2 million in Q3 2016.
- Average Net Cash Flow over 5 years is $751.8 million, with a median of -$72.0 million recorded in 2016.
- Year-over-year, Net Cash Flow slumped 322.73% in 2016 and soared 6845.21% in 2017.
- Over 5 years, Net Cash Flow stood at -$72.0 million in 2016, then jumped by 6845.21% to $4.9 billion in 2017, then sank by 72.95% to $1.3 billion in 2018, then tumbled by 124.72% to -$324.9 million in 2019, then soared by 59.92% to -$130.2 million in 2020.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$130.2 million in Q1 2020, -$324.9 million in Q4 2019, and -$541.8 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | -2.05 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 2.00 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 4.17 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -1.53 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -9.27 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 2.91 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 75.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 544.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -324.92 Mn |
| Dec 31, 2019 | -324.92 Mn |
| Dec 31, 2018 | 1.31 Bn |
| Dec 31, 2018 | 1.31 Bn |
| Dec 31, 2017 | 4.86 Bn |
| Dec 31, 2017 | 4.86 Bn |
| Dec 31, 2016 | -72.03 Mn |
| Dec 31, 2016 | -72.03 Mn |
| Dec 31, 2015 | -1.29 Bn |
| Dec 31, 2015 | -1.29 Bn |
| Dec 31, 2014 | -1.88 Bn |
| Dec 31, 2014 | -1.88 Bn |
| Dec 31, 2013 | 503.55 Mn |
| Dec 31, 2013 | 503.55 Mn |
| Sep 30, 2013 | 190.39 Mn |
| Sep 30, 2013 | 190.39 Mn |
| Jun 30, 2013 | 223.51 Mn |
| Jun 30, 2013 | 223.51 Mn |
| Mar 31, 2013 | 50.28 Mn |
| Mar 31, 2013 | 50.28 Mn |